ClinConnect Analysis: Flu, MENA/China Sponsors, Cancer & Psilocybin
{
"content": "Clinical trial teams entering late 2024 and 2025 are juggling seasonality, geography, competing oncology demand, and a surprising rise in patient interest for psychedelic therapies. This guide breaks down concrete tactics drawn from recent trial site reports and aggregated 2024-20...
Robert Maxwell
Sep 24, 2025
breast cancer therapy
Hypertension RCTs
diabetic macular edema
psilocybin therapy